We firstly examined the cell cycle status of NPC cells with ZNF750 or FGF14 overexpression after 5-ethynyl-2′-deoxyuridine (EdU) incorporation, which showed that ZNF750 or FGF14 did not alter the cell cycle status (Fig. 7a, b). The gene discussed is FGF14; the disease is nasopharyngeal carcinoma.